Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. VZ
10. LMT

Go back to Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results

Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 8c

November 7, 2017 4:16 PM EST

Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of ($0.03), $0.08 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $41.3 million versus the consensus estimate of $43.92 million.

Sees Q4 combined net product sales from both HETLIOZ and Fanapt $42 to $48 million

For earnings history... More